News
Bicycle Therapeutics and Genentech to Develop and Commercialize Bicycle based Immuno oncology Therapies
Bicycle Therapeutics plc, a biotechnology company pioneering a new and differentiated class of therapeutics based on its proprietary bicyclic peptide (Bicycle®) technology, announced that it has entered into a strategic collaboration agreement with Genentech, a member of the Roche...
Clinical Trials
Biocons Insulin Manufacturing Facility in Malaysia Completes U.S. FDA Inspection
This is to inform you that the U.S. FDA conducted a pre-approval inspection (PAI) of our subsidiary, Biocon Sdn. Bhd’s Insulins manufacturing facility based in Malaysia, for Insulin Glargine, between Feb 10 and Feb 21, 2020.
At the conclusion of...
News
RedHill Biopharma Acquires Rights to Movantik from AstraZeneca
RedHill Biopharma Ltd. , a specialty biopharmaceutical company primarily focused on the commercialization and development of proprietary drugs for the treatment of gastrointestinal (“GI”) diseases, announced that it is acquiring the global rights to Movantik® (naloxegol)1, excluding Europe, Canada...
News
ICON Acquires European CRO MedPass International
ICON plc, a global provider of drug and device development and commercialisation services to pharmaceutical, biotechnology, medical device industries, announced that it has acquired MedPass International, the leading European medical device CRO, regulatory and reimbursement consultancy, that specialises in...
News
DuPont Nutrition & Biosciences Enters into Collaboration with Microbiome Specialist MRM Health
DuPont Nutrition & Biosciences announced a collaboration with the MRM Health NV, a biopharmaceutical company, focused on the discovery and development of innovative therapeutics based on the human microbiome. MRM Health also confirmed the successful completion of its first...
News
Key Themes and Technologies Highlighted at Pharmapack Europe 2020
Improving adherence to medication via smarter, patient-centric pharmaceutical packaging and extracting further value from existing medicines and delivery devices are two of the latest key strategies aimed at reducing waste and protecting the bottom line, according to experts at...
News
Almac Group launches enhanced Label Approval Solution (LAS)
Almac Clinical Services, a member of the global contract pharmaceutical development and manufacturing organisation, the Almac Group, has announced the launch of its enhanced Label Approval Solution (LAS) – a fully compliant and validated system providing sponsors with an...
Subscribe
- Never miss a story with notifications
- Gain full access to our premium content
- Browse free from any location or device.
Must read